 | • レポートコード：MRC2-11QY11254 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はカルチノイド症候群下痢治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、ソマトスタチンアナログ（SSA）療法、経口療法）市場規模、用途別（病院、クリニック、がん研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別カルチノイド症候群下痢治療の競争状況、市場シェア ・世界のカルチノイド症候群下痢治療市場：種類別市場規模 2015年-2020年（化学療法、ソマトスタチンアナログ（SSA）療法、経口療法） ・世界のカルチノイド症候群下痢治療市場：種類別市場規模予測 2021年-2026年（化学療法、ソマトスタチンアナログ（SSA）療法、経口療法） ・世界のカルチノイド症候群下痢治療市場：用途別市場規模 2015年-2020年（病院、クリニック、がん研究所） ・世界のカルチノイド症候群下痢治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、がん研究所） ・北米のカルチノイド症候群下痢治療市場分析：米国、カナダ ・ヨーロッパのカルチノイド症候群下痢治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのカルチノイド症候群下痢治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のカルチノイド症候群下痢治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのカルチノイド症候群下痢治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Lexicon Pharmaceuticals、Novartis International、Pharmascience、Omega Laboratories、Teva Pharmaceutical Industries、Mylan、Ipsen、Sirtex Medical、BTG International ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Carcinoid syndrome is a group of symptoms that can occur in patients suffering from carcinoid tumors which also called as metastatic neuroendocrine tumors. Carcinoid tumors are rare and these are slow growing tumors. Most of the tumors occur in gastrointestinal tract. According to FDA, carcinoid syndrome occurs in less than 10 percent of people suffering from carcinoid tumors, mostly after the tumor has spread to the liver. This syndrome causes overproduction of serotonin hormone which results in chronic diarrhea. Chronic diarrhea leads to malnutrition, weight loss, electrolyte imbalance and dehydration.
Carcinoid syndrome diarrhea is a rare condition. Treatment available for this condition are expected to get orphan drug status. Government and regulatory body support for development of orphan drug and incentives are expected to drive carcinoid syndrome treatment market. Government allow companies to set high price for the orphan drug and which in turn will generate high revenue. Ineffectiveness of diarrhea controlling agents in case of carcinoid syndromes diarrhea will also drive the growth of this market.
Market Analysis and Insights: Global Carcinoid Syndrome Diarrhea Treatment Market
The global Carcinoid Syndrome Diarrhea Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Carcinoid Syndrome Diarrhea Treatment Scope and Market Size
Carcinoid Syndrome Diarrhea Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Carcinoid Syndrome Diarrhea Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Lexicon Pharmaceuticals
Novartis International
Pharmascience
Omega Laboratories
Teva Pharmaceutical Industries
Mylan
Ipsen
Sirtex Medical
BTG International
Market segment by Type, the product can be split into
Chemotherapy
Somatostatin Analog (SSA) Therapy
Oral Therapy
Market segment by Application, split into
Hospitals
Clinics
Cancer Research Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Carcinoid Syndrome Diarrhea Treatment Revenue
1.4 Market by Type
1.4.1 Global Carcinoid Syndrome Diarrhea Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Somatostatin Analog (SSA) Therapy
1.4.4 Oral Therapy
1.5 Market by Application
1.5.1 Global Carcinoid Syndrome Diarrhea Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Cancer Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Carcinoid Syndrome Diarrhea Treatment Market Perspective (2015-2026)
2.2 Global Carcinoid Syndrome Diarrhea Treatment Growth Trends by Regions
2.2.1 Carcinoid Syndrome Diarrhea Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Carcinoid Syndrome Diarrhea Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Carcinoid Syndrome Diarrhea Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Carcinoid Syndrome Diarrhea Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Carcinoid Syndrome Diarrhea Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Carcinoid Syndrome Diarrhea Treatment Players by Market Size
3.1.1 Global Top Carcinoid Syndrome Diarrhea Treatment Players by Revenue (2015-2020)
3.1.2 Global Carcinoid Syndrome Diarrhea Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Carcinoid Syndrome Diarrhea Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Carcinoid Syndrome Diarrhea Treatment Market Concentration Ratio
3.2.1 Global Carcinoid Syndrome Diarrhea Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Carcinoid Syndrome Diarrhea Treatment Revenue in 2019
3.3 Carcinoid Syndrome Diarrhea Treatment Key Players Head office and Area Served
3.4 Key Players Carcinoid Syndrome Diarrhea Treatment Product Solution and Service
3.5 Date of Enter into Carcinoid Syndrome Diarrhea Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Carcinoid Syndrome Diarrhea Treatment Historic Market Size by Type (2015-2020)
4.2 Global Carcinoid Syndrome Diarrhea Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2015-2020)
5.2 Global Carcinoid Syndrome Diarrhea Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Carcinoid Syndrome Diarrhea Treatment Market Size (2015-2020)
6.2 Carcinoid Syndrome Diarrhea Treatment Key Players in North America (2019-2020)
6.3 North America Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2015-2020)
6.4 North America Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Carcinoid Syndrome Diarrhea Treatment Market Size (2015-2020)
7.2 Carcinoid Syndrome Diarrhea Treatment Key Players in Europe (2019-2020)
7.3 Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2015-2020)
7.4 Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2015-2020)
8 China
8.1 China Carcinoid Syndrome Diarrhea Treatment Market Size (2015-2020)
8.2 Carcinoid Syndrome Diarrhea Treatment Key Players in China (2019-2020)
8.3 China Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2015-2020)
8.4 China Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Carcinoid Syndrome Diarrhea Treatment Market Size (2015-2020)
9.2 Carcinoid Syndrome Diarrhea Treatment Key Players in Japan (2019-2020)
9.3 Japan Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2015-2020)
9.4 Japan Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Carcinoid Syndrome Diarrhea Treatment Market Size (2015-2020)
10.2 Carcinoid Syndrome Diarrhea Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2015-2020)
11 India
11.1 India Carcinoid Syndrome Diarrhea Treatment Market Size (2015-2020)
11.2 Carcinoid Syndrome Diarrhea Treatment Key Players in India (2019-2020)
11.3 India Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2015-2020)
11.4 India Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Carcinoid Syndrome Diarrhea Treatment Market Size (2015-2020)
12.2 Carcinoid Syndrome Diarrhea Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2015-2020)
12.4 Central & South America Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Lexicon Pharmaceuticals
13.1.1 Lexicon Pharmaceuticals Company Details
13.1.2 Lexicon Pharmaceuticals Business Overview
13.1.3 Lexicon Pharmaceuticals Carcinoid Syndrome Diarrhea Treatment Introduction
13.1.4 Lexicon Pharmaceuticals Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020))
13.1.5 Lexicon Pharmaceuticals Recent Development
13.2 Novartis International
13.2.1 Novartis International Company Details
13.2.2 Novartis International Business Overview
13.2.3 Novartis International Carcinoid Syndrome Diarrhea Treatment Introduction
13.2.4 Novartis International Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020)
13.2.5 Novartis International Recent Development
13.3 Pharmascience
13.3.1 Pharmascience Company Details
13.3.2 Pharmascience Business Overview
13.3.3 Pharmascience Carcinoid Syndrome Diarrhea Treatment Introduction
13.3.4 Pharmascience Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020)
13.3.5 Pharmascience Recent Development
13.4 Omega Laboratories
13.4.1 Omega Laboratories Company Details
13.4.2 Omega Laboratories Business Overview
13.4.3 Omega Laboratories Carcinoid Syndrome Diarrhea Treatment Introduction
13.4.4 Omega Laboratories Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020)
13.4.5 Omega Laboratories Recent Development
13.5 Teva Pharmaceutical Industries
13.5.1 Teva Pharmaceutical Industries Company Details
13.5.2 Teva Pharmaceutical Industries Business Overview
13.5.3 Teva Pharmaceutical Industries Carcinoid Syndrome Diarrhea Treatment Introduction
13.5.4 Teva Pharmaceutical Industries Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020)
13.5.5 Teva Pharmaceutical Industries Recent Development
13.6 Mylan
13.6.1 Mylan Company Details
13.6.2 Mylan Business Overview
13.6.3 Mylan Carcinoid Syndrome Diarrhea Treatment Introduction
13.6.4 Mylan Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020)
13.6.5 Mylan Recent Development
13.7 Ipsen
13.7.1 Ipsen Company Details
13.7.2 Ipsen Business Overview
13.7.3 Ipsen Carcinoid Syndrome Diarrhea Treatment Introduction
13.7.4 Ipsen Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020)
13.7.5 Ipsen Recent Development
13.8 Sirtex Medical
13.8.1 Sirtex Medical Company Details
13.8.2 Sirtex Medical Business Overview
13.8.3 Sirtex Medical Carcinoid Syndrome Diarrhea Treatment Introduction
13.8.4 Sirtex Medical Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020)
13.8.5 Sirtex Medical Recent Development
13.9 BTG International
13.9.1 BTG International Company Details
13.9.2 BTG International Business Overview
13.9.3 BTG International Carcinoid Syndrome Diarrhea Treatment Introduction
13.9.4 BTG International Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020)
13.9.5 BTG International Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Carcinoid Syndrome Diarrhea Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Carcinoid Syndrome Diarrhea Treatment Revenue
Table 3. Ranking of Global Top Carcinoid Syndrome Diarrhea Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Carcinoid Syndrome Diarrhea Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Somatostatin Analog (SSA) Therapy
Table 7. Key Players of Oral Therapy
Table 8. Global Carcinoid Syndrome Diarrhea Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Carcinoid Syndrome Diarrhea Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Carcinoid Syndrome Diarrhea Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Carcinoid Syndrome Diarrhea Treatment Market Share by Regions (2015-2020)
Table 12. Global Carcinoid Syndrome Diarrhea Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Carcinoid Syndrome Diarrhea Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Carcinoid Syndrome Diarrhea Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Carcinoid Syndrome Diarrhea Treatment Players
Table 19. Global Carcinoid Syndrome Diarrhea Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Carcinoid Syndrome Diarrhea Treatment Market Share by Players (2015-2020)
Table 21. Global Top Carcinoid Syndrome Diarrhea Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carcinoid Syndrome Diarrhea Treatment as of 2019)
Table 22. Global Carcinoid Syndrome Diarrhea Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Carcinoid Syndrome Diarrhea Treatment Product Solution and Service
Table 25. Date of Enter into Carcinoid Syndrome Diarrhea Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Carcinoid Syndrome Diarrhea Treatment Market Size Share by Type (2015-2020)
Table 29. Global Carcinoid Syndrome Diarrhea Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Carcinoid Syndrome Diarrhea Treatment Market Size Share by Application (2015-2020)
Table 31. Global Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Carcinoid Syndrome Diarrhea Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Carcinoid Syndrome Diarrhea Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Carcinoid Syndrome Diarrhea Treatment Market Share (2019-2020)
Table 35. North America Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Carcinoid Syndrome Diarrhea Treatment Market Share by Type (2015-2020)
Table 37. North America Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Carcinoid Syndrome Diarrhea Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Carcinoid Syndrome Diarrhea Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Carcinoid Syndrome Diarrhea Treatment Market Share (2019-2020)
Table 41. Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Carcinoid Syndrome Diarrhea Treatment Market Share by Type (2015-2020)
Table 43. Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Carcinoid Syndrome Diarrhea Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Carcinoid Syndrome Diarrhea Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Carcinoid Syndrome Diarrhea Treatment Market Share (2019-2020)
Table 47. China Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Carcinoid Syndrome Diarrhea Treatment Market Share by Type (2015-2020)
Table 49. China Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Carcinoid Syndrome Diarrhea Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Carcinoid Syndrome Diarrhea Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Carcinoid Syndrome Diarrhea Treatment Market Share (2019-2020)
Table 53. Japan Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Carcinoid Syndrome Diarrhea Treatment Market Share by Type (2015-2020)
Table 55. Japan Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Carcinoid Syndrome Diarrhea Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Carcinoid Syndrome Diarrhea Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Carcinoid Syndrome Diarrhea Treatment Market Share (2019-2020)
Table 59. Southeast Asia Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Carcinoid Syndrome Diarrhea Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Carcinoid Syndrome Diarrhea Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Carcinoid Syndrome Diarrhea Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Carcinoid Syndrome Diarrhea Treatment Market Share (2019-2020)
Table 65. India Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Carcinoid Syndrome Diarrhea Treatment Market Share by Type (2015-2020)
Table 67. India Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Carcinoid Syndrome Diarrhea Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Carcinoid Syndrome Diarrhea Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Carcinoid Syndrome Diarrhea Treatment Market Share (2019-2020)
Table 71. Central & South America Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Carcinoid Syndrome Diarrhea Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Carcinoid Syndrome Diarrhea Treatment Market Share by Application (2015-2020)
Table 75. Lexicon Pharmaceuticals Company Details
Table 76. Lexicon Pharmaceuticals Business Overview
Table 77. Lexicon Pharmaceuticals Product
Table 78. Lexicon Pharmaceuticals Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020) (Million US$)
Table 79. Lexicon Pharmaceuticals Recent Development
Table 80. Novartis International Company Details
Table 81. Novartis International Business Overview
Table 82. Novartis International Product
Table 83. Novartis International Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020) (Million US$)
Table 84. Novartis International Recent Development
Table 85. Pharmascience Company Details
Table 86. Pharmascience Business Overview
Table 87. Pharmascience Product
Table 88. Pharmascience Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020) (Million US$)
Table 89. Pharmascience Recent Development
Table 90. Omega Laboratories Company Details
Table 91. Omega Laboratories Business Overview
Table 92. Omega Laboratories Product
Table 93. Omega Laboratories Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020) (Million US$)
Table 94. Omega Laboratories Recent Development
Table 95. Teva Pharmaceutical Industries Company Details
Table 96. Teva Pharmaceutical Industries Business Overview
Table 97. Teva Pharmaceutical Industries Product
Table 98. Teva Pharmaceutical Industries Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020) (Million US$)
Table 99. Teva Pharmaceutical Industries Recent Development
Table 100. Mylan Company Details
Table 101. Mylan Business Overview
Table 102. Mylan Product
Table 103. Mylan Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020) (Million US$)
Table 104. Mylan Recent Development
Table 105. Ipsen Company Details
Table 106. Ipsen Business Overview
Table 107. Ipsen Product
Table 108. Ipsen Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020) (Million US$)
Table 109. Ipsen Recent Development
Table 110. Sirtex Medical Business Overview
Table 111. Sirtex Medical Product
Table 112. Sirtex Medical Company Details
Table 113. Sirtex Medical Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020) (Million US$)
Table 114. Sirtex Medical Recent Development
Table 115. BTG International Company Details
Table 116. BTG International Business Overview
Table 117. BTG International Product
Table 118. BTG International Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2015-2020) (Million US$)
Table 119. BTG International Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Carcinoid Syndrome Diarrhea Treatment Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Somatostatin Analog (SSA) Therapy Features
Figure 4. Oral Therapy Features
Figure 5. Global Carcinoid Syndrome Diarrhea Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Cancer Research Institutes Case Studies
Figure 9. Carcinoid Syndrome Diarrhea Treatment Report Years Considered
Figure 10. Global Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Carcinoid Syndrome Diarrhea Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Carcinoid Syndrome Diarrhea Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Carcinoid Syndrome Diarrhea Treatment Market Share by Players in 2019
Figure 15. Global Top Carcinoid Syndrome Diarrhea Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carcinoid Syndrome Diarrhea Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Carcinoid Syndrome Diarrhea Treatment Revenue in 2019
Figure 17. North America Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Carcinoid Syndrome Diarrhea Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
カルチノイド症候群管理の世界市場（～2026年） Carcinoid syndrome comprises of signs and symptoms including flushing of the face, debilitating diarrhea, asthma caused due to vasoconstriction, intestinal bleeding, fast heartbeat, shortness of breath, sweating, unexplained weight gain etc. which are settled secondary to carcinoid tumor. The manage…- アスペルガー症候群治療の世界市場（～2026年） The Asperger syndrome is a type of developmental disorders known as Autistic Spectrum Disorder (ASD). These disorders initiate in childhood and stay with individuals until their adult life. Children with the Asperger syndrome function better than those with autism, and they have normal intelligence …
- 腫瘍随伴症候群治療の世界市場（～2026年） A paraneoplastic syndrome is a rare group of disorder that is triggered by an abnormal immune system response caused by the neoplasm. This syndrome mostly occurs when cancer-fighting antibodies mistakenly attack normal cells in the nervous system. The prevalence of this disorder can be typically see…
- 化学療法薬誘発性肢端紅斑（手足症候群）治療の世界市場（～2026年） Acral erythema, also called as hand-foot syndrome or palmar-plantar erythrodysesthesia, is characterized by swelling, redness, paraesthesia (numbness) and desquamation (skin peeling) of palms, soles and rarely on knees and elbow. Acryl erythema is an adverse drug reaction which typically appear afte…
- 多嚢胞性卵巣症候群治療の世界市場（～2026年） Polycystic ovary syndrome is a set of symptoms due to elevated androgens in females. Signs and symptoms of polycystic ovary syndrome nclude irregular or no menstrual periods, heavy periods, excess body and facial hair, acne, pelvic pain, difficulty getting pregnant and patches of thick, darker, velv…